SYN1
protein-codingsynapsin I, the group of Synapsins
Gene summary
This gene is a member of the synapsin gene family. Synapsins encode neuronal phosphoproteins which associate with the cytoplasmic surface of synaptic vesicles. Family members are characterized by common protein domains, and they are implicated in synaptogenesis and the modulation of neurotransmitter release, suggesting a potential role in several neuropsychiatric diseases. This member of the synapsin family plays a role in regulation of axonogenesis and synaptogenesis. The protein encoded serves as a substrate for several different protein kinases and phosphorylation may function in the regulation of this protein in the nerve terminal. Mutations in this gene may be associated with X-linked disorders with primary neuronal degeneration such as Rett syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
- MRX50
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~48.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010339
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010339
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: XL
Disease ID:MONDO:0100148
Submitter: ClinGen
*SYN1* was first reported in relation to X-linked complex neurodevelopmental disorder in 2004 (Garcia *et al*., PMID: 14985377). To date, more than 40 *SYN1* variants, mostly truncating, have been reported in individuals with variable neurodevelopmental phenotypes, including behavioral disturbances such as autism spectrum disorder or attention deficit-hyperactivity disorder (91%), epilepsy (82%), intellectual disability (77%), and developmental delay (70%) (PMID: 36568968). Reflex epilepsy, including bathing epilepsy, is characteristic of *SYN1*-related disorder. *SYN1* variants co-segregating with disease have been reported in several large families (PMIDs: 14985377, 21441247, 28973667, 36568968). *SYN1* variants predominantly affect males, while females exhibit a wider clinical heterogeneity and incomplete penetrance. This gene-disease relationship is also supported by experimental evidence. *SYN1* encodes synapsin 1, a presynaptic phosphoprotein involved in synaptic development, function, and plasticity. *Syn1* knock-out mice exhibit enhanced stimulation-evoked epileptic seizures and autism-related behavioral abnormalities (PMIDs: 7568107, 7568108, 23280234). Overexpression of *SYN1* nonsense variants in hippocampal neurons from *Syn1* knock-out mice result in impaired axon elongation, disrupted synaptic vesicle pools, and formation of perinuclear aggregates (PMIDs: 21441247, 23818987). In summary, there is definitive evidence supporting the relationship between *SYN1* and X-linked complex neurodevelopmental disorder. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on April 5, 2023 (SOP Version 9). This gene-disease relationship was originally evaluated on December 5, 2018 and given a Moderate classification. Curation of additional genetic evidence resulted in the classification being updated.
Inheritance Pattern: XL
Disease ID:MONDO:0010339
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010339
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010339
Submitter: Ambry Genetics
Inheritance Pattern: XL
Disease ID:MONDO:0010251
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SYN1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006950.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 14 | 163 | 4 | 182 | |
| missense | 1 | 4 | 285 | 27 | 2 | 319 |
| nonsense | 11 | 4 | 1 | 16 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 31 | 12 | 1 | 44 | ||
| splice donor/acceptor (+/-2bp) | 2 | 8 | 2 | 12 | ||
| Total | 45 | 30 | 304 | 190 | 6 | 575 |
Highest pathogenic variant AF is 0.0000063585053
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_008881.2 | 13 | MANE Select | |
| Ensembl | ENSP00000295987.7 | 13 | MANE Select | |
| RefSeq | NP_598006.1 | 13 | Standard | |
| Ensembl | ENSP00000343206.4 | 13 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Synaptic Vesicle Pathway
- Brain-Derived Neurotrophic Factor (BDNF) signaling pathway
- Monoamine Transport
- Neuronal System
- Dopamine Neurotransmitter Release Cycle
Biological Process
- chemical synaptic transmission
- neurotransmitter secretion
- regulation of neurotransmitter secretion
- neuron development
- synapse organization
Molecular Function
- actin binding
- transporter activity
- protein binding
- ATP binding
- protein kinase binding
Cellular Component
- synaptonemal complex
- Golgi apparatus
- cytosol
- cytoskeleton
- synaptic vesicle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000295987
- Coding exons
- 13
- Length
- 47950
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.97 | 116 | 247 | 0.469 | 0.0000196 | 4477 |
| Missense (PolyPhen) | 17 | 57.239 | 0.297 | 1005 | ||
| Synonymous | 1.44 | 91 | 110 | 0.826 | 0.00000964 | 1513 |
| Loss of Function | 3.82 | 1 | 18.9 | 0.0529 | 0.00000133 | 320 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Neuronal phosphoprotein that coats synaptic vesicles, binds to the cytoskeleton, and is believed to function in the regulation of neurotransmitter release. The complex formed with NOS1 and CAPON proteins is necessary for specific nitric-oxid functions at a presynaptic level.;
- Disease
- DISEASE: Epilepsy X-linked, with variable learning disabilities and behavior disorders (XELBD) [MIM:300491]: A neurologic disorder characterized by variable combinations of epilepsy, learning difficulties, macrocephaly, and aggressive behavior. {ECO:0000269|PubMed:14985377}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.628
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.731
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |